Anna Gutkin
Impact in
-
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 4
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 2
- CRISPR and Genetic Engineering 2
- Co-authors
- Dan Peer (6 shared papers)Zvi R. Cohen (3 shared papers)Daniel Rosenblum (3 shared papers)Nuphar Veiga (2 shared papers)Srinivas Ramishetti (2 shared papers)Ranit Kedmi (1 shared paper)Mollie S. Schubert (1 shared paper)Dinorah Friedmann‐Morvinski (2 shared papers)
- Journals
- Journal of Controlled Release (2 papers)Expert Opinion on Drug Delivery (1 paper)British Journal of Cancer (1 paper)Oncotarget (1 paper)Science Advances (1 paper)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Anna Gutkin
11 papers receiving 737 citations
Anna Gutkin's Hit Papers
Peers
Comparison fields: 5 of 68
- Business and International Management 22
- Cancer Research 149
- Molecular Biology 628
- Biomaterials 101
- Aging 11
Countries citing papers authored by Anna Gutkin
This map shows the geographic impact of Anna Gutkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gutkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gutkin more than expected).
Fields of papers citing papers by Anna Gutkin
This network shows the impact of papers produced by Anna Gutkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gutkin. The network helps show where Anna Gutkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Gutkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy Hit paper breakdown → | 2020 | 430 |
| 2 | 2016 | 104 | |
| 3 | 2017 | 48 | |
| 4 | 2016 | 48 | |
| 5 | 2020 | 46 | |
| 6 | 2021 | 41 | |
| 7 | 2018 | 16 | |
| 8 | 2025 | 4 | |
| 9 | 2023 | 3 | |
| 10 | [EXOSOMES AS MEDIATORS OF INTERCELLULAR COMMUNICATION: THE CANCER AND TELOMERASE CONNECTION]. | 2017 | 3 |
| 11 | 2017 | 1 |
About Anna Gutkin
Anna Gutkin is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Public Health, Environmental and Occupational Health and Physiology, having authored 11 papers that have together received 744 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (4 papers), RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (2 papers), Mosquito-borne diseases and control (2 papers), Nanoparticle-Based Drug Delivery (2 papers), CRISPR and Genetic Engineering (2 papers), Telomeres, Telomerase, and Senescence (2 papers) and Innovation and Socioeconomic Development (1 paper). The work is most often cited by research in Business and International Management (22 citations), Cancer Research (149 citations), Molecular Biology (628 citations), Biomaterials (101 citations) and Aging (11 citations). Anna Gutkin has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Dan Peer, Zvi R. Cohen, Daniel Rosenblum, Nuphar Veiga, Srinivas Ramishetti, Ranit Kedmi, Mollie S. Schubert, Dinorah Friedmann‐Morvinski, Mark A. Behlke and Judy Lieberman. Their work appears in journals such as Journal of Controlled Release, Expert Opinion on Drug Delivery, British Journal of Cancer, Oncotarget and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.